Welcome to our dedicated page for Health In Tech SEC filings (Ticker: HIT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Health In Tech, Inc. filings document material-event disclosures for a Nevada operating company with Class A common stock listed on the Nasdaq Capital Market under HIT. Recent Form 8-K reports cover results of operations and financial condition, Regulation FD materials, investor presentations and conference-call transcripts.
The filing record also addresses capital-structure matters, including a private investment in public equity financing, and governance disclosures involving executive officer departures, compensatory arrangements and related consulting agreements. The company identifies as an emerging growth company in its Exchange Act reports.
Health In Tech, Inc. is registering 5,600,000 shares of Class A Common Stock for resale by selling stockholders under a shelf registration. The resale shares were issued in a PIPE and the company will receive no proceeds from secondary sales.
The registration covers shares issued in the PIPE Offering that closed on March 27, 2026 and is being filed pursuant to the related Registration Rights Agreement. The prospectus lists plan of distribution options and states shares may be sold on Nasdaq (symbol HIT) or by other permitted methods.
Health In Tech, Inc. director and Chief Executive Officer Tim Donald Johnson reported a tax-related share disposition. On April 15, 2026, he surrendered 35,140 shares of Class A Common Stock at $1.50 per share to cover withholding and remittance obligations triggered by the vesting of restricted stock.
After this tax-withholding disposition, he directly holds 23,514,601 Class A shares, consisting of 1,079,624 restricted and 22,434,977 unrestricted Class A shares, and this figure excludes 9,000,000 Class B shares and 734,707 stock options.
Health In Tech, Inc. Chief Growth Officer Hasan Zain Syed surrendered 3,448 shares of Class A Common Stock at a price of $1.50 per share to the company to cover tax withholding on vested restricted stock. Following this tax-withholding disposition, he directly holds 216,552 Class A shares, including 211,552 restricted shares and 5,000 unrestricted shares.
Health In Tech, Inc. director and Chief Financial Officer Qian LinLin reported a routine tax-related share disposition. On the vesting of previously granted restricted Class A Common Stock, 21,480 shares were surrendered to the company at $1.50 per share to satisfy tax withholding and remittance obligations, rather than sold on the open market.
After this tax-withholding disposition, LinLin directly holds 9,107,075 shares of Class A Common Stock, consisting of 1,086,284 restricted shares and 8,020,791 unrestricted shares, while separately excluding 2,700,000 shares of Class B Common Stock and 711,510 options to purchase Class A Common Stock.
Health In Tech, Inc. Chief Executive Officer and 10% owner Johnson Tim Donald reported a compensation-related share transaction. On the vesting of restricted Class A Common Stock, he surrendered 35,140 shares at $1.50 per share to the company to satisfy tax withholding obligations. This Form 4 characterizes the move as a tax-withholding disposition, not an open-market sale, and indicates he continues to hold a substantial direct position in Class A Common Stock after the transaction.
McStravock John reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. reported that General Counsel John McStravock received a grant of 5,000 restricted shares of Class A Common Stock as equity compensation. These shares were granted at no cash cost to him.
The restricted shares will vest in equal monthly installments over a twelve-month period starting on April 6, 2026, as long as he continues to serve with the company through each vesting date. After this grant, he holds 5,000 Class A shares directly.
Health In Tech, Inc. filed an initial insider ownership report for its General Counsel, John McStravock. This Form 3 lists him as an officer but shows no reported stock transactions or derivative positions and no holding entries at the time of this filing.
Shrestha Sanjay K reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Sanjay K. Shrestha received a grant of 13,598 restricted shares of Class A Common Stock, valued at $1.36 per share, as compensation under the Health in Tech Equity Incentive Plan. The restricted stock vested on the grant date, bringing his direct holdings to 82,333 shares.
Howard William D. reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Howard William D. received a grant of 13,598 restricted shares of Class A Common Stock, valued at $1.36 per share, as equity compensation under the Health in Tech Equity Incentive Plan. The restricted shares vested as of the grant date, and he now directly holds a total of 119,643 Class A Common shares.
Hayes Timothy reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Timothy Hayes received a grant of 13,598 restricted shares of Class A Common Stock on April 8, 2026 under the Health in Tech Equity Incentive Plan. The filing reports the transaction at $1.36 per share.
The footnote states these restricted shares vested as of the grant date, meaning they became fully owned immediately. Following this equity award, Hayes directly holds 119,643 shares of Class A Common Stock.